Tcatinnib-(TUKYSA) -@- (Apr- 2020)- Metastatic Breast Cancer
Drug Name:
Tcatinnib-(TUKYSA) -@- (Apr- 2020)- Metastatic Breast Cancer
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2020
Sr.No- 13
Name of the Drug- TUKYSA
Active Ingredient - Tucatinib
Pharmacological Classification-
To treat Advanced unresctable or Metastatic HERZ-positive Breast Cancer
Date of Approval- 4/17/2020
(Ref- FDA approved List 2020)